AGL News and Press, agilon health inc. From 02/08/24

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Benjamin Kornitzer, M.D., will assume a strategic role as special advisor to the company and will transition from his role as chief medical officer (CMO) ef...

2024-02-07 06:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY Paper published in the journal "Current Issues in Molecular Biology" special issue: advanced solutions for cancer therapy GUILDFORD, SURREY / ACCESSWIRE / January 22, 2024 / AN...

2024-01-05 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

2024-01-05 06:17:13 ET More on agilon health agilon health: High Growth But Unsustainable Economics agilon health, inc. (AGL) Q3 2023 Earnings Call Transcript Deutsche downgrades agilon to hold, says targets "overly optimistic" agilon health hits 52-week low ...

agilon health, Inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that Timothy Bensley has informed the company of his intent to retire from his position as Chief Financial Officer (CFO) during 2024, which agilon expects to tak...

Revised 2023 expectations and early outlook for 2024 reflect higher medical and non-medical costs Company is taking targeted actions to improve visibility, balance risk-sharing, and improve predictability of results in 2024 and over the long term agilon health to h...

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 42 nd Annual J.P. Morgan Healthcare Conference including a fireside chat presentation on Tuesday, January 9 at 1:30 PM Eastern Time. ...

USE OF PARSORTIX SYSTEM IN PRE-CLINICAL MODEL UNLOCKS OPPORTUNITIES FOR DRUG DISCOVERY Harvested CTCs reveal gene expression profile associated with development and progression of brain metastasis in melanoma Researchers suggest such profiling could prove to be "pivotal" to prescribing m...

GUILDFORD, SURREY / ACCESSWIRE / December 11, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, is pleased to announce that Berenberg will ...